申请人:Neurocrine Biosciences, Inc.
公开号:US06346534B1
公开(公告)日:2002-02-12
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:
including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein Ar, B, R1, R2, R3a, R3b, R4, R5, R6 and m are as defined herein.
GnRH受体拮抗剂已被披露,可用于治疗男性和女性的各种与性激素相关的疾病。该发明的化合物具有以下结构:包括立体异构体、前药和其药用盐,其中Ar、B、R1、R2、R3a、R3b、R4、R5、R6和m的定义如本文所述。